[Palliative treatment of rectal cancer by the trans-anal approach using a urologic prostatectomy device].
Palliative treatment for patients with rectal carcinoma affect more than 10% of the 8000 cases diagnosed each year in France. Twenty-four patients underwent endoscopic trans-anal resection using a urological resectoscope. The morbidity rate was 18,5% and there were no postoperative deaths. The median hospital stay for the procedure alone was 4 days. Good palliation was obtained in 89% of cases. This simple, minimally invasive and economic method should join palliative treatment for patients with rectal carcinoma beside laser destruction and external beam radiotherapy.
Arnaud
J P
JP
Service de Chirurgie viscérale, CHU Angers.
Debras
B
B
Becouarn
G
G
Chautard
D
D
Casa
C
C
D000230:Adenocarcinoma / Q000601:surgery*; D000368:Aged; D000369:Aged, 80 and over; D004564:Electrocoagulation / Q000295:instrumentation*; D004724:Endoscopy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D011468:Prostatectomy / Q000295:instrumentation; D012004:Rectal Neoplasms / Q000601:surgery*
Traitement palliatif des cancers du rectum par voie trans-anale à l'aide du résecteur urologique à prostate.